NDT Pharmaceuticals Inc.
NDT Pharmaceuticals Inc. (NDTP) Stock Overview
Explore NDT Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
116.6M
P/E Ratio
-4702.10
EPS (TTM)
$-0.30
ROE
-0.33%
NDTP Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of NDT Pharmaceuticals Inc. (NDTP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.28.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4702.10 and a market capitalization of 116.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.